Search Results - "YAMAGUCHI, KOSUKE"

Refine Results
  1. 1

    Epigenetic modifications and reprogramming in paternal pronucleus: sperm, preimplantation embryo, and beyond by Okada, Yuki, Yamaguchi, Kosuke

    “…Pronuclear/zygotic stage is the very first stage of life. In this period, paternal pronucleus undergoes massive chromatin remodeling called “paternal…”
    Get full text
    Journal Article
  2. 2

    Utilization of Ni as a Non-Noble-Metal Co-catalyst for Ceria-Supported Rhenium Oxide in Combination of Deoxydehydration and Hydrogenation of Vicinal Diols by Yamaguchi, Kosuke, Nakagawa, Yoshinao, Li, Congcong, Yabushita, Mizuho, Tomishige, Keiichi

    Published in ACS catalysis (21-10-2022)
    “…Removal of vicinal diols by combination of deoxydehydration and hydrogenation (DODH + HG) was carried out over the mixture of ReO x /CeO2 and CeO2-supported…”
    Get full text
    Journal Article
  3. 3

    Re-evaluating the Localization of Sperm-Retained Histones Revealed the Modification-Dependent Accumulation in Specific Genome Regions by Yamaguchi, Kosuke, Hada, Masashi, Fukuda, Yuko, Inoue, Erina, Makino, Yoshinori, Katou, Yuki, Shirahige, Katsuhiko, Okada, Yuki

    Published in Cell reports (Cambridge) (26-06-2018)
    “…The question of whether retained histones in the sperm genome localize to gene-coding regions or gene deserts has been debated for years. Previous…”
    Get full text
    Journal Article
  4. 4

    Vascular endothelial growth factor signaling in VE-cadherin expression and tube-like formation by rheumatoid arthritic synovial fibroblast-like cells by Yamaguchi, Kosuke, Sudo, Haruka, Imai, Kazushi

    “…An increase in the vasculature is one of most representative changes in the synovial tissue of joints in rheumatoid arthritis (RA) and is closely associated…”
    Get full text
    Journal Article
  5. 5

    Adsorption of Keggin-Type Polyoxometalates on Rh Metal Particles under Reductive Conditions by Nakagawa, Yoshinao, Kuwata, Ayaka, Yamaguchi, Kosuke, Tamura, Masazumi, Yabushita, Mizuho, Tomishige, Keiichi

    Published in Inorganic chemistry (16-08-2021)
    “…The adsorption of POMs on Rh/SiO2 in water solvent under strongly reductive conditions was investigated. Aqueous solutions of α-Keggin type silicotungstate and…”
    Get full text
    Journal Article
  6. 6

    Structural basis for activation of DNMT1 by Kikuchi, Amika, Onoda, Hiroki, Yamaguchi, Kosuke, Kori, Satomi, Matsuzawa, Shun, Chiba, Yoshie, Tanimoto, Shota, Yoshimi, Sae, Sato, Hiroki, Yamagata, Atsushi, Shirouzu, Mikako, Adachi, Naruhiko, Sharif, Jafar, Koseki, Haruhiko, Nishiyama, Atsuya, Nakanishi, Makoto, Defossez, Pierre-Antoine, Arita, Kyohei

    Published in Nature communications (21-11-2022)
    “…DNMT1 is an essential enzyme that maintains genomic DNA methylation, and its function is regulated by mechanisms that are not yet fully understood. Here, we…”
    Get full text
    Journal Article
  7. 7

    Histone functions as a cell-surface receptor for AGEs by Itakura, Masanori, Yamaguchi, Kosuke, Kitazawa, Roma, Lim, Sei-Young, Anan, Yusuke, Yoshitake, Jun, Shibata, Takahiro, Negishi, Lumi, Sugawa, Hikari, Nagai, Ryoji, Uchida, Koji

    Published in Nature communications (27-05-2022)
    “…Reducing sugars can covalently react with proteins to generate a heterogeneous and complex group of compounds called advanced glycation end products (AGEs)…”
    Get full text
    Journal Article
  8. 8

    Antibody-Dependent Cellular Cytotoxicity Mediated by Cetuximab against Lung Cancer Cell Lines by KURAI, Jun, CHIKUMI, Hiroki, NAKAMOTO, Masaki, BURIOKA, Naoto, SHIMIZU, Eiji, HASHIMOTO, Kiyoshi, YAMAGUCHI, Kosuke, YAMASAKI, Akira, SAKO, Takanori, TOUGE, Hirokazu, MAKINO, Haruhiko, TAKATA, Miyako, MIYATA, Masanori

    Published in Clinical cancer research (01-03-2007)
    “…Purpose: Epidermal growth factor receptor (EGFR) is commonly overexpressed in lung cancer. Cetuximab is a chimeric mouse-human antibody targeted against EGFR…”
    Get full text
    Journal Article
  9. 9

    Identification of a variant-specific phosphorylation of TH2A during spermiogenesis by Hada, Masashi, Masuda, Koji, Yamaguchi, Kosuke, Shirahige, Katsuhiko, Okada, Yuki

    Published in Scientific reports (07-04-2017)
    “…Tissue-specific histone variant incorporation into chromatin plays dynamic and important roles in tissue development. Testis is one such tissue, and a number…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Large-Scale Chromatin Rearrangements in Cancer by Yamaguchi, Kosuke, Chen, Xiaoying, Oji, Asami, Hiratani, Ichiro, Defossez, Pierre-Antoine

    Published in Cancers (12-05-2022)
    “…Epigenetic abnormalities are extremely widespread in cancer. Some of them are mere consequences of transformation, but some actively contribute to cancer…”
    Get full text
    Journal Article
  12. 12

    Molecular and structural basis of anti-DNA antibody specificity for pyrrolated proteins by Anan, Yusuke, Itakura, Masanori, Shimoda, Tatsuya, Yamaguchi, Kosuke, Lu, Peng, Nagata, Koji, Dong, Jinhua, Ueda, Hiroshi, Uchida, Koji

    Published in Communications biology (03-02-2024)
    “…Anti-DNA antibodies (Abs), serological hallmarks of systemic lupus erythematosus (SLE) and markers for diagnosis and disease activity, show a specificity for…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Bronchodilator Reversibility Occurring during the Acute Phase of Paragonimiasis westermani Infection by Harada, Tomoya, Kawasaki, Yuji, Tsukada, Akira, Osawa, Yoichi, Takami, Hiroki, Yamaguchi, Kosuke, Kurai, Jun, Yamasaki, Akira, Shimizu, Eiji

    Published in Internal Medicine (15-01-2019)
    “…A 43-year-old woman was referred to our hospital with peripheral blood hypereosinophilia and abnormal chest X-ray findings. Her pleural effusion revealed…”
    Get full text
    Journal Article
  15. 15

    Pembrolizumab-induced asthma exacerbation with hypereosinophilia and elevated interleukin-5 in endometrial cancer: A case report by Harada, Tomoya, Uetani, Naoki, Inui, Genki, Ishikawa, Hiroki, Funaki, Yoshihiro, Takata, Miki, Okazaki, Ryota, Yamaguchi, Kosuke, Morita, Masato, Kitatani, Shin, Yamasaki, Akira

    Published in Respiratory medicine case reports (01-01-2024)
    “…Pembrolizumab is an anti-programmed cell death-1 (PD-1) antibody used to treat various cancer types. Treatments with such immune checkpoint inhibitors cause…”
    Get full text
    Journal Article
  16. 16

    Diagnostic and prognostic impact of serum‐soluble UL16‐binding protein 2 in lung cancer patients by Yamaguchi, Kosuke, Chikumi, Hiroki, Shimizu, Asuka, Takata, Miyako, Kinoshita, Naoki, Hashimoto, Kiyoshi, Nakamoto, Masaki, Matsunaga, Shinji, Kurai, Jun, Miyake, Naomi, Matsumoto, Shingo, Watanabe, Masanari, Yamasaki, Akira, Igishi, Tadashi, Burioka, Naoto, Shimizu, Eiji

    Published in Cancer science (01-08-2012)
    “…UL16‐binding protein 2 (ULBP2) is one of the ligands for NKG2D (NKG2DL). ULBP2 expression is induced in transformed cells and is recognized by immune effector…”
    Get full text
    Journal Article
  17. 17

    Effect of Cetuximab and EGFR Small Interfering RNA Combination Treatment in NSCLC Cell Lines with Wild Type EGFR and Use of KRAS as a Possible Biomarker for Treatment Responsiveness by Miyake, Naomi, Chikumi, Hiroki, Yamaguchi, Kosuke, Takata, Miyako, Takata, Miki, Okada, Kensaku, Kitaura, Tsuyoshi, Nakamoto, Masaki, Yamasaki, Akira

    Published in Yonago acta medica (01-03-2019)
    “…The epidermal growth factor receptor (EGFR) is a therapeutic target for patients with non-small cell lung cancer (NSCLC). Cetuximab is an anti-EGFR monoclonal…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers by Yamaguchi, Kosuke, Iglesias-Bartolomé, Ramiro, Wang, Zhiyong, Callejas-Valera, Juan Luis, Amornphimoltham, Panomwat, Molinolo, Alfredo A, Cohen, Ezra E, Califano, Joseph A, Lippman, Scott M, Luo, Ji, Gutkind, J Silvio

    Published in Oncotarget (08-03-2016)
    “…mTOR inhibition has emerged as a promising strategy for head and neck squamous cell carcinomas (HNSCC) treatment. However, most targeted therapies ultimately…”
    Get full text
    Journal Article